213 related articles for article (PubMed ID: 10535607)
1. Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy.
Ohshima S; Saeki Y; Mima T; Sasai M; Nishioka K; Ishida H; Shimizu M; Suemura M; McCloskey R; Kishimoto T
J Clin Immunol; 1999 Sep; 19(5):305-13. PubMed ID: 10535607
[TBL] [Abstract][Full Text] [Related]
2. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
[TBL] [Abstract][Full Text] [Related]
3. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.
Lorenz HM; Grünke M; Hieronymus T; Antoni C; Nüsslein H; Schaible TF; Manger B; Kalden JR
J Rheumatol; 2000 Feb; 27(2):304-10. PubMed ID: 10685789
[TBL] [Abstract][Full Text] [Related]
4. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
[TBL] [Abstract][Full Text] [Related]
5. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
[TBL] [Abstract][Full Text] [Related]
7. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
Paleolog EM; Hunt M; Elliott MJ; Feldmann M; Maini RN; Woody JN
Arthritis Rheum; 1996 Jul; 39(7):1082-91. PubMed ID: 8670315
[TBL] [Abstract][Full Text] [Related]
8. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
9. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
[TBL] [Abstract][Full Text] [Related]
10. In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects.
Lorenz HM; Antoni C; Valerius T; Repp R; Grünke M; Schwerdtner N; Nüsslein H; Woody J; Kalden JR; Manger B
J Immunol; 1996 Feb; 156(4):1646-53. PubMed ID: 8568271
[TBL] [Abstract][Full Text] [Related]
11. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
12. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis.
Mangge H; Gallistl S; Schauenstein K
J Interferon Cytokine Res; 1999 Sep; 19(9):1005-10. PubMed ID: 10505742
[TBL] [Abstract][Full Text] [Related]
15. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis.
Amital H; Barak V; Winkler RE; Rubinow A
Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
17. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.
Moreland LW; Bucy RP; Tilden A; Pratt PW; LoBuglio AF; Khazaeli M; Everson MP; Daddona P; Ghrayeb J; Kilgarriff C
Arthritis Rheum; 1993 Mar; 36(3):307-18. PubMed ID: 8095785
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
[TBL] [Abstract][Full Text] [Related]
19. Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2).
Perkins DJ; St Clair EW; Misukonis MA; Weinberg JB
Arthritis Rheum; 1998 Dec; 41(12):2205-10. PubMed ID: 9870877
[TBL] [Abstract][Full Text] [Related]
20. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
